GleamWall
中文EN

ABSI Absci Corp

Services-Commercial Physical & Biological Research · Nasdaq · SEC CIK 1672688 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-47.2%
TTM net income YoY-9.7%
TTM EPS YoY13.2%
Revenue 3-yr CAGR-40.2%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-8,812.3%
Net margin-8,451.3%
FCF margin-7,562.7%
EBITDA margin-8,076.6%

Returns

ROE-58.6%
ROA-51.9%
ROIC (approx.)-53.3%
Asset turnover0.01x

Leverage & solvency

Liabilities / assets8.7%
Debt / equity0.00x
Current ratio9.64x
Interest coverage-2,569.39x

Cash quality & payout

Operating cash flow / net income0.90x
Accruals ratio-5.4%
Payout ratio—
Capex / revenue-4.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$304,000$318,000$215,000$650,000$378,000$593,000$1.18M$665,000
R&D expense$23.57M$22.62M$19.27M$25.35M$19.25M$20.46M$16.36M$18.38M
SG&A expense$9.04M$9.16M$9.06M$8.62M$8.44M$8.53M$9.47M$8.83M
Operating income-$34.99M-$34.16M-$30.85M-$31.04M-$30.15M-$31.39M-$27.73M-$29.77M
Interest expense$2,000$2,000$18,000$29,000$45,000$56,000$79,000$109,000
Pretax income-$33.28M-$33.17M-$29.58M-$29.72M-$28.60M-$30.44M-$26.35M-$28.96M
Income tax$18,000$40,000$18,000-$162,000$104,000$131,000-$4,000$21,000
Net income-$33.30M-$33.21M-$29.60M-$29.56M-$28.71M-$30.57M-$26.35M-$28.98M
EBITDA-$32.31M-$31.46M-$28.12M-$28.21M-$27.31M-$28.39M-$24.66M-$26.54M
EPS (basic)-0.19-0.21-0.19—-0.20-0.24-0.21—
EPS (diluted)-0.19-0.21-0.19—-0.20-0.24-0.21—
Weighted avg. shares (diluted)171.80M157.47M152.96M—143.77M127.59M124.46M—
Balance sheet
Cash & equivalents$13.36M$107.86M$8.63M$20.02M$26.87M$55.29M$64.12M$58.21M
Short-term investments$160.37M$93.28M$117.08M$124.27M$143.00M——$71.21M
Receivables————$1.00M$700,000$1.38M$0
Current assets$181.89M$208.27M$131.97M$149.57M$174.99M$137.40M$155.98M$133.83M
PP&E, net$14.76M$16.72M$18.78M$20.86M$23.02M$24.06M$27.03M$29.17M
Intangibles$39.33M$40.05M$40.77M$41.51M$42.36M$43.20M$44.04M$44.88M
Total assets$239.57M$268.92M$195.59M$216.30M$244.99M$209.89M$232.45M$213.61M
Current liabilities$18.86M$19.60M$20.03M$22.77M$29.71M$31.32M$27.28M$28.66M
Long-term debt———————$3.99M
Total debt———————$3.99M
Total liabilities$20.90M$22.79M$23.62M$26.85M$34.65M$36.52M$33.65M$34.48M
Shareholders' equity$218.68M$246.13M$171.97M$189.45M$210.34M$173.37M$198.80M$179.13M
Net debt———————-$54.22M
Shares outstanding———————115.36M
Cash flow statement
Operating cash flow-$29.47M-$27.56M-$26.31M-$29.18M-$25.03M-$16.87M-$21.84M-$16.96M
Capital expenditure$9,000$1,000$30,000-$103,000$962,000$223,000$25,000$23,000
Free cash flow-$29.48M-$27.57M-$26.34M-$29.08M-$25.99M-$17.10M-$21.86M-$16.99M
Investing cash flow-$67.05M$24.07M$7.36M$19.55M-$63.70M$9.04M-$15.04M$19.04M
Financing cash flow$2.02M$102.73M$7.56M$3.84M$60.32M-$1.00M$42.79M$986,000
Depreciation & amortization$2.69M$2.70M$2.73M$2.83M$2.84M$3.00M$3.07M$3.23M
Stock-based compensation$4.47M$5.25M$4.38M$4.26M$4.40M$4.75M$4.91M$5.07M

Free plan shows the latest 8 periods; Pro shows all 27 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.